Inquiry The antimicrobial potential of bacteriophages
Witnesses Dr Jean-Paul Pirnay (Head of the Laboratory of Molecular and Cellular Technology at Queen Astrid Military Hospital, Brussels), Dr Mzia Kutateladze (Director at George Eliava Institute of Bacteriophage, Microbiology and Virology), Professor Jon Iredell (Director, Centre for Infectious Diseases and Microbiology at The Westmead Institute for Medical Research), Professor Robert Schooley (Professor of Division of Infectious Diseases at UC San Diego School of Medicine), Greg Merril (Chief Operating Officer at Adaptive Phage Therapeutics), Dr Hans Petter Kleppen (Chief Science Officer at ACD Pharma), and Naomi Zak (Founder at BiomX)
Inquiry The antimicrobial potential of bacteriophages
Witnesses Professor Martha Clokie (Professor of Microbiology at University of Leicester), Professor Cath Rees (Professor of Microbiology at University of Nottingham), Professor Joanne M. Santini (Professor of Microbiology at University College London), Dr Josh Jones (Clinical Phage Specialist at NHS Tayside), Dr James Soothill (Consultant Microbiologist at Great Ormond Street Hospital Laboratory Medicine), Ms Stephanie Lesage (Co-Founder/Director and Chief Executive Officer at Oxford Silk Phage Technologies Ltd), and Mr David Browning (Chief Executive Officer at Fixed Phage LTD)